Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API


Protalix BioTherapeutics Q3 EPS $(0.14) Beats $(0.17) Estimate, Sales $10.79M Beat $10.08M Estimate


Benzinga | Oct 29, 2020 07:14AM EDT

Protalix BioTherapeutics Q3 EPS $(0.14) Beats $(0.17) Estimate, Sales $10.79M Beat $10.08M Estimate

Protalix BioTherapeutics (AMEX:PLX) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.17) by 17.65 percent. This is a 600 percent decrease over losses of $(0.02) per share from the same period last year. The company reported quarterly sales of $10.79 million which beat the analyst consensus estimate of $10.08 million by 7.04 percent. This is a 24.27 percent decrease over sales of $14.25 million the same period last year.






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC